UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The iboga enigma: the chemistry and neuropharmacology of iboga alkaloids and related analogs

Natural product reports, 2021-03, Vol.38 (2), p.37-329

2021

Volltextzugriff (PDF)

A non-hallucinogenic psychedelic analogue with therapeutic potential

Nature (London), 2021-01, Vol.589 (7842), p.474-479

2021

Volltextzugriff (PDF)

The pharmacokinetics and pharmacodynamics of ibogaine in opioid use disorder patients

Journal of psychopharmacology (Oxford), 2024-05, Vol.38 (5), p.481-488

2024

Volltextzugriff (PDF)

Serotonin transporter-ibogaine complexes illuminate mechanisms of inhibition and transport

Nature (London), 2019-05, Vol.569 (7754), p.141-145

2019

Volltextzugriff (PDF)

Influence of CYP2D6 activity on the pharmacokinetics and pharmacodynamics of a single 20 mg dose of ibogaine in healthy volunteers

Journal of clinical pharmacology, 2015-06, Vol.55 (6), p.680-687

2015

Volltextzugriff (PDF)

Ascending-dose study of noribogaine in healthy volunteers: Pharmacokinetics, pharmacodynamics, safety, and tolerability

Journal of clinical pharmacology, 2015-02, Vol.55 (2), p.189-194

2015

Volltextzugriff (PDF)

Effects of low dose ibogaine on subjective mood state and psychological performance

Journal of ethnopharmacology, 2016-08, Vol.189, p.10-13

2016

Volltextzugriff (PDF)

Voacamine alters Leishmania ultrastructure and kills parasite by poisoning unusual bi-subunit topoisomerase IB

Biochemical pharmacology, 2017-08, Vol.138, p.19-30

2017

Volltextzugriff (PDF)

Synthesis of (−)-Pseudotabersonine, (−)-Pseudovincadifformine, and (+)-Coronaridine Enabled by Photoredox Catalysis in Flow

Journal of the American Chemical Society, 2014-07, Vol.136 (29), p.10270-10273

2014

Volltextzugriff (PDF)

How toxic is ibogaine?

Clinical toxicology (Philadelphia, Pa.), 2016-04, Vol.54 (4), p.297-302

2016

Volltextzugriff (PDF)

hERG Blockade by Iboga Alkaloids

Cardiovascular toxicology, 2016-01, Vol.16 (1), p.14-22

2016

Volltextzugriff (PDF)

The anti-addiction drug ibogaine and the heart: a delicate relation

Molecules, 2015-02, Vol.20 (2), p.2208-2228

2015

Volltextzugriff (PDF)

Conformational dynamics of the human serotonin transporter during substrate and drug binding

Nature communications, 2019-04, Vol.10 (1), p.1687-1687, Article 1687

2019

Volltextzugriff (PDF)

Treatment of opioid use disorder with ibogaine: detoxification and drug use outcomes

The American journal of drug and alcohol abuse, 2018-01, Vol.44 (1), p.24-36

2018

Volltextzugriff (PDF)

Toxicokinetics of ibogaine and noribogaine in a patient with prolonged multiple cardiac arrhythmias after ingestion of internet purchased ibogaine

Clinical toxicology (Philadelphia, Pa.), 2017-07, Vol.55 (6), p.600-602

2017

Volltextzugriff (PDF)

Noribogaine is a G-protein biased κ-opioid receptor agonist

Neuropharmacology, 2015-12, Vol.99, p.675-688

2015

Volltextzugriff (PDF)

A natural product, voacamine, sensitizes paclitaxel-resistant human ovarian cancer cells

Toxicology and applied pharmacology, 2022-01, Vol.434, p.115816, Article 115816

2022

Volltextzugriff (PDF)

Selectivity of coronaridine congeners at nicotinic acetylcholine receptors and inhibitory activity on mouse medial habenula

The international journal of biochemistry & cell biology, 2017-11, Vol.92, p.202-209

2017

Volltextzugriff (PDF)

Potent Anti-amoebic Effects of Ibogaine, Voacangine and the Root Bark Alkaloid Fraction of Tabernaemontana arborea

Planta medica, 2023-02, Vol.89 (2), p.148-157

2023

Volltextzugriff (PDF)

Coronaridine congeners inhibit human α3β4 nicotinic acetylcholine receptors by interacting with luminal and non-luminal sites

The international journal of biochemistry & cell biology, 2015-08, Vol.65, p.81-90

2015

Volltextzugriff (PDF)

What We Have Gained from Ibogaine: α3β4 Nicotinic Acetylcholine Receptor Inhibitors as Treatments for Substance Use Disorders

Journal of medicinal chemistry, 2023-01, Vol.66 (1), p.107-121

2023

Volltextzugriff (PDF)

Treating drug dependence with the aid of ibogaine: A retrospective study

Journal of psychopharmacology (Oxford), 2014-11, Vol.28 (11), p.993-1000

2014

Volltextzugriff (PDF)

Reactivity of the Iboga Skeleton: Oxidation Study of Ibogaine and Voacangine

Journal of natural products (Washington, D.C.), 2023-06, Vol.86 (6), p.1500-1511

2023

Volltextzugriff (PDF)

Ibogaine as a treatment for substance misuse: Potential benefits and practical dangers

Progress in brain research, 2018, Vol.242, p.217-257

2018

Volltextzugriff (PDF)

Identification of Indole Alkaloid Structural Units Important for Stimulus-Selective TRPM8 Inhibition: SAR Study of Naturally Occurring Iboga Derivatives

Journal of natural products (Washington, D.C.), 2014-08, Vol.77 (8), p.1831-1838

2014

Volltextzugriff (PDF)

1 – 25 von 568

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(491)
Mit Volltextzugriff
(436)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

6 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

The iboga enigma: the chemistry and neuropharmacology of iboga alkaloids and related analogs

A non-hallucinogenic psychedelic analogue with therapeutic potential

The pharmacokinetics and pharmacodynamics of ibogaine in opioid use disorder patients

Serotonin transporter-ibogaine complexes illuminate mechanisms of inhibition and transport

Influence of CYP2D6 activity on the pharmacokinetics and pharmacodynamics of a single 20 mg dose of ibogaine in healthy volunteers

Ascending-dose study of noribogaine in healthy volunteers: Pharmacokinetics, pharmacodynamics, safety, and tolerability

Effects of low dose ibogaine on subjective mood state and psychological performance

Voacamine alters Leishmania ultrastructure and kills parasite by poisoning unusual bi-subunit topoisomerase IB

Synthesis of (−)-Pseudotabersonine, (−)-Pseudovincadifformine, and (+)-Coronaridine Enabled by Photoredox Catalysis in Flow

How toxic is ibogaine?

hERG Blockade by Iboga Alkaloids

The anti-addiction drug ibogaine and the heart: a delicate relation

Conformational dynamics of the human serotonin transporter during substrate and drug binding

Treatment of opioid use disorder with ibogaine: detoxification and drug use outcomes

Toxicokinetics of ibogaine and noribogaine in a patient with prolonged multiple cardiac arrhythmias after ingestion of internet purchased ibogaine

Noribogaine is a G-protein biased κ-opioid receptor agonist

A natural product, voacamine, sensitizes paclitaxel-resistant human ovarian cancer cells

Selectivity of coronaridine congeners at nicotinic acetylcholine receptors and inhibitory activity on mouse medial habenula

Potent Anti-amoebic Effects of Ibogaine, Voacangine and the Root Bark Alkaloid Fraction of Tabernaemontana arborea

Coronaridine congeners inhibit human α3β4 nicotinic acetylcholine receptors by interacting with luminal and non-luminal sites

What We Have Gained from Ibogaine: α3β4 Nicotinic Acetylcholine Receptor Inhibitors as Treatments for Substance Use Disorders

Treating drug dependence with the aid of ibogaine: A retrospective study

Reactivity of the Iboga Skeleton: Oxidation Study of Ibogaine and Voacangine

Ibogaine as a treatment for substance misuse: Potential benefits and practical dangers

Identification of Indole Alkaloid Structural Units Important for Stimulus-Selective TRPM8 Inhibition: SAR Study of Naturally Occurring Iboga Derivatives

Suchergebnisse filtern